Improving survival of melanoma patients in Europe since 1978

European Journal of Cancer

Volumn 34, Issue 14, 1998, Pages 2197-2203

  Smith, J A E ^a   Whatley, P M ^a   Redburn, J C ^b   Oberaigner, W ^c   Storm, H ^d   Aareleid, T ^e   Hakulinen, T ^f   MacELesec'h, J ^g   Arveux, P ^h   Esteve, J ⁱ   Raverdy, N ^j   Ziegler, H ^k   Tryggvadottir, L ^l   Tulinius, H ^l   Berrino, F ^m   Crosignani, P ^m   Gatta, G ^m   Micheli, A ^m   Sant, M ^m   Conti, E ⁿ   Vercelli, M ^o   Federico, M ^p   Mangone, L ^p   De Lisi, V ^q   Zanetti, R ^r   Gafa, L ^s   Tumino, R ^s   Falcini, F ^t   Barchielli, A ^u   Capocaccia, R ^v   De Angelis, G ^v   Valente, F ^v   Verdecchia, A ^v   Pawlega, J ^w   Rachtan, J ^w   Bielska Lasota, M ^x   Wronkowski, Z ^x   Obsitnikova, A ^y   Plesko, I ^y   PompeKirn, V ^z   Izarzugaza, I ^aa   Garau, I ^ab   Ardanaz, E ^ac   Moreno, C ^ac   Galceran, J ^ad   Moller, T ^ae   Torhorst, J ^af   Bouchardy, C ^ag   Raymond, L ^ag   Coebergh, J W W ^ah   Gould, A ^ai   Black, R J ^ai   Davies, T W ^aj   Stockton, D ^aj   Coleman, M P ^ak   Williams, E M I ^al   Littler, J ^al   Forman, D ^am   Quinn, M J ^an   Roche, M ^b   Smith, J ^a   Bell, J ^ao   Lawrence, G ^ap   more..

^a S and West Cancer Intelligence Unit   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Cancer Registry of Tyrol   (Denmark)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e Estonian Cancer Registry   (Finland)

^f Finnish Cancer Registry   (France)

^g Calvados General Cancer Registry   (Côte d’Ivoire)

^h Doubs Cancer Registry   (France)

ⁱ INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^j Somme Cancer Registry   (Germany)

^k Saarland Cancer Registry   (Iceland)

^l Icelandic Cancer Registry   (Italy)

^m Lombardy Cancer Registry   (France)

ⁿ Latina Cancer Registry   (France)

^o Liguria Cancer Registry   (Italy)

^p MODENA CANCER REGISTRY   (Italy)

^q PARMA CANCER REGISTRY   (Italy)

^r Center for Epidemiology and Prevention in Oncology   (Italy)

^s Ragusa Cancer Registry   (Italy)

^t Romagna Cancer Registry   (Italy)

^u Tuscan Cancer Registry   (Italy)

^v NATIONAL INSTITUTES OF HEALTH   (United States)

^w Cracow Cancer Registry   (Poland)

^x INSTITUTE OF ONCOLOGY   (Poland)

^y National Cancer Registry of Slovakia   (Slovenia)

^z INSTITUTE OF ONCOLOGY   (Slovenia)

^aa Departamento de Sanidad Gobierno Vasco   (Spain)

^ab Mallorca Cancer Registry   (Spain)

^ac Navarra Cancer Registry   (Italy)

^ad Tarragona Cancer Registry   (Sweden)

^ae Southern Swedish Regional Tumour Registry   (Switzerland)

^af Cancer Registry of Basel   (Switzerland)

^ag GENEVA CANCER REGISTRY   (Switzerland)

^ah Eindhoven Cancer Registry   (United Kingdom)

^ai Scottish Cancer Registry   (United Kingdom)

^aj East Anglian Cancer Registry   (United Kingdom)

^ak LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^al Merseyside and Cheshire Cancer Registry   (United Kingdom)

^am Northern and Yorkshire Cancer Registry and Information Service   (United Kingdom)

^an OYce for National Statistics   (United Kingdom)

^ao Thames Cancer Registry   (United Kingdom)

^ap W Midlands Cancer Intelligence Unit   (United Kingdom)

more..

Author keywords

Europe; Primary cutaneous melanoma; Prognostic factors; Survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; COMPUTER PROGRAM; EUROPE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 0032439077     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00321-9     Document Type: Article

References (20)

1. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of cancer patients in Europe: the EUROCARE Study. IARC Scientific Publications No. 132. Lyon, International Agency for Research on Cancer, 1995.
2. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents, Volume VI. IARC Scientific Publications No. 120. Lyon, International Agency for Research on Cancer, 1992.
3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. IARC Scientific Publications No. 121. Lyon, International Agency for Research on Cancer, 1993.
4. Cancer statistics: registrations 1991 Series MBI No 24. Office for National Statistics (a publication of the Government Statistical Service), 1997.
5. Balzi D., Carli P., Geddes M. Malignant melanoma in Europe: changes in mortality rates (1970-90) in European community countries. Cancer Causes Control. 8:1997;85-92.
6. Cole C.A., Forbes P.D., Davies R.E. An action spectrum for UV photocarcinogenesis. Photochem Photobiol. 43:1986;275-284.
7. Melia J., Ellman R., Chamberlain J. Meeting the Health of the Nation target for skin cancer: problems with tackling prevention and monitoring trends. J Pub Health Med. 16:1994;225-232.
8. Hakulinen T., Abeywickrama K.H. A computer program package for relative survival analysis. Computer Progr Biomed. 19:1985;197-207.
9. Mackie RM, ed. Malignant melanoma: a guide to early diagnosis. Glasgow University, Glasgow, U.K., 1989.
10. Rees GJG, Goodman SE, Bullimore JA. Cancer in Practice. Butterworth-Heinemann Ltd, Oxford, 1993.
11. Masback A, Westerdahl J, Ingvar C, Olsson H, Jonsson N. Cutaneous malignant melanoma in Southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations. Cancer 1997, 79, 275-283.
12. Heenan P.J., English D.R., Holman C.D., Armstong B.K. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma. Cancer. 69:1992;421-426.
13. Corona R, Scio M, Mele A, et al. Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy. Eur J Cancer 1994, 30A, 333-338.
14. Mackie R.M., Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. Br Med J. 304:1992;1012-1015.
15. Bulliard JL, Raymond L, Levi F, et al. Prevention of cutaneous melanoma: an epidemiological evaluation of the Swiss campaign. Rev Epidemiol Sante Publique 1992, 40, 431-438.
16. Drzewiecki K.T., Frydman H., Andersen K., Poulsen H., Ladefoged C., Vibe P. Malignant melanoma: changing trends in factors influencing metastasis-free survival from 1964-1982. Cancer. 65:1990;362-366.
17. Mackie R.M., Hole D.J. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socio-economic status. Br Med J. 312:1996;1125-1128.
18. Thorn M., Porten F., Bergstom R., Sparen P., Adami H-O. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer. 70:1994;743-748.
19. Mackie RM, Hole D, Hunter J, et al. Cutaneous malignant melanoma in Scotland: incidence, survival and mortality 1979-94. Br Med J 1997, 315, 1117-1121.
20. Kosary CI, Ries LAG, Millar BA, Hankey BF, Harras A, Edwards BK (Eds). SEER Cancer Statistics Review 1973-1992: Tables and graphs, National Cancer Institute, N.H. Pub. No. 96-2789. Bethesda, MD 1995.